Adenovirus mediated gene transfer to skeletal muscle

Microscopy Research and Technique

Volumn 58, Issue 1, 2002, Pages 45-51

  Cao, Baohong ^a,b   Mytinger, John R ^a,b   Huard, Johnny ^a,b,c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Adenovirus; Maturation dependent; Skeletal muscle

Indexed keywords

BACTERIOPHAGES; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; STEM CELLS; VECTORS;

ADENOVIRUS; EXTRACELLULAR MATRICES; IMMUNOREJECTION; MATURATION-DEPENDENT; MUSCLE TISSUES; MUSCULAR DYSTROPHY; MYOBLASTS; MYOFIBERS; SKELETAL MUSCLE; THERAPEUTIC GENES;

MUSCLE;

ADENOVIRUS VECTOR;

ADENOVIRUS; ARTICLE; EXTRACELLULAR MATRIX; GENE EXPRESSION; GENE TRANSFER; IMMUNOGENICITY; MUSCLE CELL; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; SKELETAL MUSCLE; TRANSGENE; TREATMENT PLANNING;

ADENOVIRIDAE;

EID: 0036644037     PISSN: 1059910X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jemt.10116     Document Type: Article

References (94)

1. Human dystrophin expression in mdx mice after intramuscular injection of DNA constructs
2. Differential efficiency of adenovirus-mediated in vivo gene transfer into skeletal muscle cells of different maturity
3. Dystrophin expression in muscles of mdx mice after adenovirus-mediated in vivo gene transfer
4. Multiple regulatory elements contribute differentially to muscle creatine kinase enhancer activity in skeletal and cardiac muscle
5. Dynamics of myoblast transplantation reveal a discrete minority of precursors with stem cell-like properties as the myogenic source
6. Isolation of a common receptor for Coxsackie B viruses and adenovirus 2 and 5
7. Myoblast mediated ex vivo gene transfer to mature muscle
8. In vivo therapy of hepatocellular carcinoma with a tumor-specific adenoviral vector expressing interleukin-2
9. The role of receptors in the maturation-dependent adenoviral transduction of myofibers
10. Regulation of creatine kinase induction in differentiating mouse myoblasts
11. In vivo muscle gene transfer of full-length dystrophin with an adenoviral vector that lacks all viral genes
12. Overexpression of dystrophin in transgenic mdx mice eliminates dystrophic symptoms without toxicity
13. MHox: A mesodermally restricted homeodomain protein that binds an essential site in the muscle creatine kinase enhancer
14. Engineering tissue-specific expression of a recombinant adenovirus: Selective transgene transcription in the pancreas using the amylase promoter
15. Analysis of muscle creatine kinase gene regulatory elements in skeletal and cardiac muscles of transgenic mice
16. Strategies to accomplish targeted gene delivery to muscle cells employing tropism-modified adenoviral vectors
17. Targeted gene delivery by tropism-modified adenoviral vectors
18. Gene transfer into nerve and muscle by isolated limb perfusion or during replantation
19. Retroviral-mediated transfer of a dystrophin minigene into mdx mouse myoblasts in vitro
20. Viral gene delivery to skeletal muscle: Insights on maturation-dependent loss of fiber infectivity for adenovirus and herpes simplex type 1 viral vectors
21. Recombinant adenovirus deleted of all viral genes for gene therapy of cystic fibrosis
22. Ex vivo gene transfer using adenovirus mediated full-length dystrophin delivery to dystrophic muscles
23. Analysis of tissue-specific gene delivery by recombinant adenoviruses containing cardiac-specific promoters
24. Adenovirus type 5 and 7 capsid chimera: Fiber replacement alters receptor tropism without affecting primary immune neutralization epitopes
25. Expression of αvβ5 integrin is necessary for efficient adenovirus-mediated gene transfer in the human airway
26. Development of prostate-specific antigen promoter-based gene therapy for androgen-independent human prostate cancer
27. Stepwise dismantling of adenovirus 2 during entry into cells
28. Stable restoration of the sarcoglycan complex in dystrophic muscle perfused with histamine and a recombinant adeno-associated viral vector
29. Control of inflammatory damage by anti-LFA-1: Increase success of myoblast transplantation
30. The fate of individual myoblasts after transplantation into muscles of DMD patients
31. Interferon-gamma inhibits transgene expression driven by SV40 or CMV promoters but augments expression driven by the mammalian MHC I promoter
32. Developments in gene therapy for muscular dystrophy
33. Improved production of gutted adenovirus in cells expressing adenovirus preterminal protein and DNA polymerase
34. Analysis of muscle creatine kinase regulatory elements in recombinant adenoviral vectors
35. CAR-dependent and CAR-independent pathways of adenovirus vector-mediated gene transfer and expression in human fibroblasts
36. Dystrophin: The protein product of the Duchenne muscular dystrophy locus
37. Adenovirus type 5 fiber knob binds to MHC class I alpha2 domain at the surface of human epithelial and B lymphoblastoid cells
38. Enhancement of adenovirus-mediated gene delivery by use of an oligopeptide with dual binding specificity
39. Upregulation of integrins. αvβ3 and αvβ5 on human monocytes and T lymphocytes facilitates adenovirus-mediated gene delivery
40. Gene transfer into skeletal muscles by isogenic myoblasts
41. The basal lamina is a physical barrier to herpes simplex virus-mediated gene delivery to mature muscle fibers
42. Transcriptional regulation of the muscle creatine kinase gene and regulated expression in transfected mouse myoblasts
43. Muscle creatine kinase sequence elements regulating skeletal and cardiac muscle expression in transgenic mice
44. Transduction of dendritic cells by DNA viral vectors directs the immune response to transgene products in muscle fibers
45. Gene therapy for alpha-fetoprotein-producing human hepatoma cells by adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene
46. Myoblast transfer in Duchenne muscular dystrophy
47. A new adenoviral vector: Replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and beta-galactosidase
48. Generation of recombinant adenovirus vectors with modified fibers for altering viral tropism
49. Encapsidated adenovirus minichromosomes allow delivery and expression of a 14 kb dystrophin cDNA to muscle cells
50. Tumor-specific gene expression in carcinoembryonic antigen - Producing gastric cancer cells using adenovirus vectors
51. Efficient muscle-specific transgene expression after adenovirus-mediated gene transfer in mice using a 1.35 kb muscle creatine kinase promoter/enhancer
52. Clonal isolation of muscle-derived cells capable of enhancing muscle regeneration and bone healing
53. Adenoviral-mediated gene transfer in lymphocytes
54. Reactivation of the previously silenced cytomegalovirus major immediate-early promoter in the mouse liver: Involvement of NFkappaB
55. In vivo gene transfer into tendon by recombinant adenovirus
56. Interactions of soluble recombinant integrin avb5 with human adenoviruses
57. Myoblast transfer in the treatment of Duchenne's muscular dystrophy
58. Addition of a short peptide ligand to the adenovirus fiber protein
59. Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts
60. Virus-receptor interaction in an adenovirus system
61. Development of approaches to improve cell survival in myoblast transfer therapy
62. Adenovirus as an expression vector in muscle cells in vivo
63. Efficient adenovirus-mediated transfer of a human minidystrophin gene to skeletal muscle of mdx mice
64. Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy
65. Retroviral vector-mediated gene transfer into human primary myogenic cells leads to expression in muscle fibers in vivo
66. HBV-derived promoters direct liver-specific expression of an adenovirally transduced LDL receptor gene
67. Enhanced and specific gene expression via tissue-specific production of Cre recombinase using adenovirus vector
68. Modulation of the specificity and activity of a cellular promoter in an adenoviral vector
69. E-box sites and a proximal regulatory region of the muscle creatine kinase gene differentially regulate expression in diverse skeletal muscles and cardiac muscle of transgenic mice
70. Human adenovirus serotypes 3 and 5 bind to two different cellular receptors via the fiber head domain
71. Deficiency of merosin in dystrophic dy mice and genetic linkage of laminin M chain gene to dy locus
72. Adenovirus-mediated gene therapy of gastric carcinoma using cancer-specific gene expression in vivo
73. HCAR and MCAR: The human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses
74. Intramuscular migration of myoblasts transplanted after muscle pretreatment with metalloproteinases
75. Developmental regulation and tissue-specific expression of the human muscle creatine kinase gene
76. Results of a triple blind clinical study of myoblast transplantations without immunosuppressive treatment in young boys with Duchenne muscular dystrophy
77. Implications of maturation for viral gene delivery to skeletal muscle
78. Muscle maturation: Implications for gene therapy
79. Extended tropism of an adenoviral vector does not circumvent the maturation-dependent transducibility of mouse skeletal muscle
80. Long-term correction of mouse dystrophic degeneration by adenovirus-mediated transfer of a minidystrophin gene
81. The 'adenobody' approach to viral targeting: Specific and enhanced adenoviral gene delivery
82. Immunoelectron microscopic localization of dystrophin in myofibres
83. Inventory of high-abundance mRNAs in skeletal muscle of normal men
84. Systemic delivery of the interleukin-1 receptor antagonist protein using a new strategy of direct adenoviral-mediated gene transfer to skeletal muscle capillary endothelium in the isolated rat hindlimb
85. Targeting adenovirus
86. Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment
87. Integrin alpha v beta 5 selectively promotes adenovirus mediated cell membrane permeabilization
88. Adenovirus targeted to heparan-containing receptors increases its gene delivery efficiency to multiple cell types
89. Targeted adenovirus gene transfer to endothelial and smooth muscle cells by using bispecific antibodies
90. Increased in vitro and in vivo gene transfer by adenovirus vectors containing chimeric fiber proteins
91. Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus
92. Full functional rescue of a complete muscle (TA) in dystrophic hamsters by adeno-associated virus vector-directed gene therapy
93. Defective muscle basement membrane and lack of M-laminin in the dystrophic dy/dy mouse
94. Murine muscular dystrophy caused by a mutation in the laminin alpha 2 (Lama2) gene